Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
Christiane Berger-Schaffitzel, Co-founder and CTO at Halo Therapeutics, shared post on LinkedIn:
“Exciting PhD Opportunity:
Applications are now open for our SWBio DTP-funded PhD project at the University of Bristol ‘Characterisation and Inhibition of Snake Venom Metalloproteinases for Next-Generation Antivenom’ co-supervised by Prof. Alastair Poole and me.
You will combine protein engineering, nanobody discovery, blood coagulation and platelet biology, and venom research to develop innovative approaches to neutralise SVMPs, key drivers of snakebite pathology.
You will receive training in eukaryotic protein expression, ribosome display, protein engineering, and functional haemostasis assays.
Application deadline: Midday, Wednesday 2 December
Stay updated with Hemostatis Today.
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results
-
Oct 27, 2026, 11:42Cece Calhoun: ASH Promotes Clinical Research Training and Mentorship for Emerging Hematologists
-
Oct 27, 2026, 11:41Ifeanyichukwu Ifechidere: The Laboratory Challenges of Measuring Direct Factor Xa Inhibitors
-
Oct 27, 2026, 11:39Gene Therapy Offers New Possibilities for Patients with Thalassaemia in the UAE – Thalassaemia International Federation
-
Oct 27, 2026, 11:35Alan Nurden: rFVIIa Prophylaxis May Reduce Bleeding-Related Healthcare Burden in Glanzmann Thrombasthenia